Kids Choose Nasal Spray Flu Vaccine Over Traditional Shot

Most children and adults, for that matter, simply detest vaccine injections. Yet a report from the Advisory Committee on Immunization Practices (ACIP) of the U.S. Centers for Disease Control and Prevention (CDC) shows that some can be given via a nasal spray, instead. The research specifically examines a nasal flu vaccine that children chose over the traditional shot.

"I agree with the panel's recommendation," said Dr. Mare Siegel, an associate professor of medicine at NYU Langone Medical Center in New York City, via HealthDay. "Kids don't like shots, so the spray is a perfect alternative."

Researchers found that the spray triggered a strong immune response in children who had not suffered from the flu in the past. However, the spray may not be appropriate for children dealing with asthma or other respiratory conditions, according to the American Academy of Pediatrics (AAP).

Michael Brady, M.D., of Ohio State University and AAP's committee on infectious disease said he does not believe this recommendation will alter traditional practices that much, particularly this year.

However, some health providers are already using the nasal spray, known as FluMist. The flu vaccine spray, which was approved in 2003 for individuals between the ages of two and 49, is manufactured by AstraZeneca and more expensive than a traditional shot at $23. Typical needle shots are about $8 to $22.

"[The ACIP] is following steps that have already occurred in Europe," Dr. Gloria Riefkohl, a pediatrician at Miami Children's Hospital, stated. "In our practice, we recommend the nasal vaccine for all healthy children up to 21."

However, Dr. Riefkohl reiterates that the ACIP's recommendation should not discourage parents and children from getting the seasonal flu shot.